Global Swine Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Swine Vaccines market size was valued at US$ 1650 million in 2025 and is forecast to a readjusted size of US$ 2152 million by 2032 with a CAGR of 3.9% during review period.
Swine vaccines are biological preparations designed to prevent and control infectious diseases in pigs by stimulating specific antibody and cellular immune responses. They are classified into inactivated, live attenuated, subunit, recombinant, and nucleic acid vaccines, widely applied against key swine diseases such as classical swine fever, PRRS, pseudorabies, foot-and-mouth disease, porcine circovirus, and mycoplasmal pneumonia. As modern pig farming shifts toward intensive and high-efficiency operations, swine vaccines have become essential tools for improving herd health, enhancing productivity, ensuring food safety, and safeguarding public health. The industry’s innovation trend is evolving from traditional prophylaxis to precision immunization and multivalent combination vaccine technologies. In 2024, global Swine vaccines production reached approximately 12.56 billion units , with an average global market price of around US$ 123 k unit.The average gross profit margin for this product is 70%.
The global swine vaccine market is experiencing structural growth opportunities. The ongoing threat of highly pathogenic diseases such as African swine fever and PRRS has prompted governments to strengthen animal health infrastructure, while companies increasingly prioritize preventive immunization over therapeutic solutions. Meanwhile, advances in biotechnology and genetic engineering are accelerating the commercialization of next-generation vaccines—including DNA, mRNA, and adjuvant-optimized formulations—creating new growth engines for global animal health leaders. In regions such as China, Southeast Asia, and Latin America, rapid consolidation of pig farming is boosting demand for high-safety, broad-spectrum vaccines, marking a new phase of technology-driven and brand-oriented competition.
Despite its strong outlook, the industry faces multiple risks including regulatory complexity, technological barriers, and market volatility. Stricter vaccine approval procedures—especially for recombinant and genetic vaccines—extend product launch timelines and increase R&D costs, limiting smaller firms’ participation. In addition, fluctuating raw material prices, cold-chain logistics requirements, and unpredictable outbreaks create operational uncertainty. The circulation of unlicensed vaccines and inconsistent immunization practices in certain regions further undermine market integrity and trust.
Demand from pig producers is shifting from “disease prevention” toward “integrated herd health management.” Large-scale farms and agri-food conglomerates are adopting comprehensive immunization solutions, accelerating the adoption of multivalent and precision vaccination systems. Growing consumer concerns over pork safety and traceability are reinforcing the need for regulated vaccination programs. Future market evolution will emphasize the integration of immunization monitoring, digital farming, and biosecurity management, fostering a value-driven, data-linked vaccine ecosystem.
The upstream supply chain of swine vaccines includes antigens, culture media, adjuvants, stabilizers, and packaging materials. Optimizing antigen production and virus culture systems remains key to cost control and batch consistency. Some premium vaccine components—such as advanced cell media and imported adjuvants—still rely on international suppliers, posing supply chain risks. However, with advances in domestic fermentation, synthetic biology, and formulation technologies, local substitution is accelerating. High-purity materials and customized bioreactor systems are expected to become crucial differentiators for vaccine manufacturers.
This report is a detailed and comprehensive analysis for global Swine Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Swine Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Swine Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Swine Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Vaccines, with price, sales quantity, revenue, and global market share of Swine Vaccines from 2021 to 2026.
Chapter 3, the Swine Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Swine Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Vaccines.
Chapter 14 and 15, to describe Swine Vaccines sales channel, distributors, customers, research findings and conclusion.
Swine vaccines are biological preparations designed to prevent and control infectious diseases in pigs by stimulating specific antibody and cellular immune responses. They are classified into inactivated, live attenuated, subunit, recombinant, and nucleic acid vaccines, widely applied against key swine diseases such as classical swine fever, PRRS, pseudorabies, foot-and-mouth disease, porcine circovirus, and mycoplasmal pneumonia. As modern pig farming shifts toward intensive and high-efficiency operations, swine vaccines have become essential tools for improving herd health, enhancing productivity, ensuring food safety, and safeguarding public health. The industry’s innovation trend is evolving from traditional prophylaxis to precision immunization and multivalent combination vaccine technologies. In 2024, global Swine vaccines production reached approximately 12.56 billion units , with an average global market price of around US$ 123 k unit.The average gross profit margin for this product is 70%.
The global swine vaccine market is experiencing structural growth opportunities. The ongoing threat of highly pathogenic diseases such as African swine fever and PRRS has prompted governments to strengthen animal health infrastructure, while companies increasingly prioritize preventive immunization over therapeutic solutions. Meanwhile, advances in biotechnology and genetic engineering are accelerating the commercialization of next-generation vaccines—including DNA, mRNA, and adjuvant-optimized formulations—creating new growth engines for global animal health leaders. In regions such as China, Southeast Asia, and Latin America, rapid consolidation of pig farming is boosting demand for high-safety, broad-spectrum vaccines, marking a new phase of technology-driven and brand-oriented competition.
Despite its strong outlook, the industry faces multiple risks including regulatory complexity, technological barriers, and market volatility. Stricter vaccine approval procedures—especially for recombinant and genetic vaccines—extend product launch timelines and increase R&D costs, limiting smaller firms’ participation. In addition, fluctuating raw material prices, cold-chain logistics requirements, and unpredictable outbreaks create operational uncertainty. The circulation of unlicensed vaccines and inconsistent immunization practices in certain regions further undermine market integrity and trust.
Demand from pig producers is shifting from “disease prevention” toward “integrated herd health management.” Large-scale farms and agri-food conglomerates are adopting comprehensive immunization solutions, accelerating the adoption of multivalent and precision vaccination systems. Growing consumer concerns over pork safety and traceability are reinforcing the need for regulated vaccination programs. Future market evolution will emphasize the integration of immunization monitoring, digital farming, and biosecurity management, fostering a value-driven, data-linked vaccine ecosystem.
The upstream supply chain of swine vaccines includes antigens, culture media, adjuvants, stabilizers, and packaging materials. Optimizing antigen production and virus culture systems remains key to cost control and batch consistency. Some premium vaccine components—such as advanced cell media and imported adjuvants—still rely on international suppliers, posing supply chain risks. However, with advances in domestic fermentation, synthetic biology, and formulation technologies, local substitution is accelerating. High-purity materials and customized bioreactor systems are expected to become crucial differentiators for vaccine manufacturers.
This report is a detailed and comprehensive analysis for global Swine Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Swine Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Swine Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Swine Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
- Government Tender
- Market Sales
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
- Cavet Bio
- BIGVET Biotech
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Swine Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Vaccines, with price, sales quantity, revenue, and global market share of Swine Vaccines from 2021 to 2026.
Chapter 3, the Swine Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Swine Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Vaccines.
Chapter 14 and 15, to describe Swine Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 CSF Vaccines
1.3.3 FMD Vaccines
1.3.4 Porcine Circovirus Vaccines
1.3.5 PRRS Vaccines
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Global Swine Vaccines Market Size & Forecast
1.5.1 Global Swine Vaccines Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Swine Vaccines Sales Quantity (2021-2032)
1.5.3 Global Swine Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Swine Vaccines Product and Services
2.1.4 Merck Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Swine Vaccines Product and Services
2.2.4 Boehringer Ingelheim Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Jinyu Bio-Technology
2.3.1 Jinyu Bio-Technology Details
2.3.2 Jinyu Bio-Technology Major Business
2.3.3 Jinyu Bio-Technology Swine Vaccines Product and Services
2.3.4 Jinyu Bio-Technology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Jinyu Bio-Technology Recent Developments/Updates
2.4 CAHIC
2.4.1 CAHIC Details
2.4.2 CAHIC Major Business
2.4.3 CAHIC Swine Vaccines Product and Services
2.4.4 CAHIC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 CAHIC Recent Developments/Updates
2.5 Tecon
2.5.1 Tecon Details
2.5.2 Tecon Major Business
2.5.3 Tecon Swine Vaccines Product and Services
2.5.4 Tecon Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tecon Recent Developments/Updates
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Swine Vaccines Product and Services
2.6.4 Zoetis Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Zoetis Recent Developments/Updates
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Swine Vaccines Product and Services
2.7.4 Ceva Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Ceva Recent Developments/Updates
2.8 Hile Bio
2.8.1 Hile Bio Details
2.8.2 Hile Bio Major Business
2.8.3 Hile Bio Swine Vaccines Product and Services
2.8.4 Hile Bio Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hile Bio Recent Developments/Updates
2.9 Chopper Biology
2.9.1 Chopper Biology Details
2.9.2 Chopper Biology Major Business
2.9.3 Chopper Biology Swine Vaccines Product and Services
2.9.4 Chopper Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Chopper Biology Recent Developments/Updates
2.10 WINSUN
2.10.1 WINSUN Details
2.10.2 WINSUN Major Business
2.10.3 WINSUN Swine Vaccines Product and Services
2.10.4 WINSUN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 WINSUN Recent Developments/Updates
2.11 Hipra
2.11.1 Hipra Details
2.11.2 Hipra Major Business
2.11.3 Hipra Swine Vaccines Product and Services
2.11.4 Hipra Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hipra Recent Developments/Updates
2.12 Ringpu Biology
2.12.1 Ringpu Biology Details
2.12.2 Ringpu Biology Major Business
2.12.3 Ringpu Biology Swine Vaccines Product and Services
2.12.4 Ringpu Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Ringpu Biology Recent Developments/Updates
2.13 ChengDu Tecbond
2.13.1 ChengDu Tecbond Details
2.13.2 ChengDu Tecbond Major Business
2.13.3 ChengDu Tecbond Swine Vaccines Product and Services
2.13.4 ChengDu Tecbond Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 ChengDu Tecbond Recent Developments/Updates
2.14 DHN
2.14.1 DHN Details
2.14.2 DHN Major Business
2.14.3 DHN Swine Vaccines Product and Services
2.14.4 DHN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 DHN Recent Developments/Updates
2.15 CAVAC
2.15.1 CAVAC Details
2.15.2 CAVAC Major Business
2.15.3 CAVAC Swine Vaccines Product and Services
2.15.4 CAVAC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 CAVAC Recent Developments/Updates
2.16 Virbac
2.16.1 Virbac Details
2.16.2 Virbac Major Business
2.16.3 Virbac Swine Vaccines Product and Services
2.16.4 Virbac Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Virbac Recent Developments/Updates
2.17 HVRI
2.17.1 HVRI Details
2.17.2 HVRI Major Business
2.17.3 HVRI Swine Vaccines Product and Services
2.17.4 HVRI Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 HVRI Recent Developments/Updates
2.18 Bioveta
2.18.1 Bioveta Details
2.18.2 Bioveta Major Business
2.18.3 Bioveta Swine Vaccines Product and Services
2.18.4 Bioveta Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Bioveta Recent Developments/Updates
2.19 Cavet Bio
2.19.1 Cavet Bio Details
2.19.2 Cavet Bio Major Business
2.19.3 Cavet Bio Swine Vaccines Product and Services
2.19.4 Cavet Bio Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cavet Bio Recent Developments/Updates
2.20 BIGVET Biotech
2.20.1 BIGVET Biotech Details
2.20.2 BIGVET Biotech Major Business
2.20.3 BIGVET Biotech Swine Vaccines Product and Services
2.20.4 BIGVET Biotech Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 BIGVET Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SWINE VACCINES BY MANUFACTURER
3.1 Global Swine Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Swine Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Swine Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Swine Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Swine Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Swine Vaccines Manufacturer Market Share in 2025
3.5 Swine Vaccines Market: Overall Company Footprint Analysis
3.5.1 Swine Vaccines Market: Region Footprint
3.5.2 Swine Vaccines Market: Company Product Type Footprint
3.5.3 Swine Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Swine Vaccines Market Size by Region
4.1.1 Global Swine Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Swine Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Swine Vaccines Average Price by Region (2021-2032)
4.2 North America Swine Vaccines Consumption Value (2021-2032)
4.3 Europe Swine Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Swine Vaccines Consumption Value (2021-2032)
4.5 South America Swine Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Swine Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Swine Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Swine Vaccines Consumption Value by Type (2021-2032)
5.3 Global Swine Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Swine Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Swine Vaccines Consumption Value by Application (2021-2032)
6.3 Global Swine Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Swine Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Swine Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Swine Vaccines Market Size by Country
7.3.1 North America Swine Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Swine Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Swine Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Swine Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Swine Vaccines Market Size by Country
8.3.1 Europe Swine Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Swine Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Swine Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Swine Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Swine Vaccines Market Size by Region
9.3.1 Asia-Pacific Swine Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Swine Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Swine Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Swine Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Swine Vaccines Market Size by Country
10.3.1 South America Swine Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Swine Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Swine Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Swine Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Swine Vaccines Market Size by Country
11.3.1 Middle East & Africa Swine Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Swine Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Swine Vaccines Market Drivers
12.2 Swine Vaccines Market Restraints
12.3 Swine Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Swine Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Vaccines
13.3 Swine Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Vaccines Typical Distributors
14.3 Swine Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 CSF Vaccines
1.3.3 FMD Vaccines
1.3.4 Porcine Circovirus Vaccines
1.3.5 PRRS Vaccines
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Global Swine Vaccines Market Size & Forecast
1.5.1 Global Swine Vaccines Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Swine Vaccines Sales Quantity (2021-2032)
1.5.3 Global Swine Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Swine Vaccines Product and Services
2.1.4 Merck Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Swine Vaccines Product and Services
2.2.4 Boehringer Ingelheim Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Jinyu Bio-Technology
2.3.1 Jinyu Bio-Technology Details
2.3.2 Jinyu Bio-Technology Major Business
2.3.3 Jinyu Bio-Technology Swine Vaccines Product and Services
2.3.4 Jinyu Bio-Technology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Jinyu Bio-Technology Recent Developments/Updates
2.4 CAHIC
2.4.1 CAHIC Details
2.4.2 CAHIC Major Business
2.4.3 CAHIC Swine Vaccines Product and Services
2.4.4 CAHIC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 CAHIC Recent Developments/Updates
2.5 Tecon
2.5.1 Tecon Details
2.5.2 Tecon Major Business
2.5.3 Tecon Swine Vaccines Product and Services
2.5.4 Tecon Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tecon Recent Developments/Updates
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Swine Vaccines Product and Services
2.6.4 Zoetis Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Zoetis Recent Developments/Updates
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Swine Vaccines Product and Services
2.7.4 Ceva Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Ceva Recent Developments/Updates
2.8 Hile Bio
2.8.1 Hile Bio Details
2.8.2 Hile Bio Major Business
2.8.3 Hile Bio Swine Vaccines Product and Services
2.8.4 Hile Bio Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hile Bio Recent Developments/Updates
2.9 Chopper Biology
2.9.1 Chopper Biology Details
2.9.2 Chopper Biology Major Business
2.9.3 Chopper Biology Swine Vaccines Product and Services
2.9.4 Chopper Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Chopper Biology Recent Developments/Updates
2.10 WINSUN
2.10.1 WINSUN Details
2.10.2 WINSUN Major Business
2.10.3 WINSUN Swine Vaccines Product and Services
2.10.4 WINSUN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 WINSUN Recent Developments/Updates
2.11 Hipra
2.11.1 Hipra Details
2.11.2 Hipra Major Business
2.11.3 Hipra Swine Vaccines Product and Services
2.11.4 Hipra Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hipra Recent Developments/Updates
2.12 Ringpu Biology
2.12.1 Ringpu Biology Details
2.12.2 Ringpu Biology Major Business
2.12.3 Ringpu Biology Swine Vaccines Product and Services
2.12.4 Ringpu Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Ringpu Biology Recent Developments/Updates
2.13 ChengDu Tecbond
2.13.1 ChengDu Tecbond Details
2.13.2 ChengDu Tecbond Major Business
2.13.3 ChengDu Tecbond Swine Vaccines Product and Services
2.13.4 ChengDu Tecbond Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 ChengDu Tecbond Recent Developments/Updates
2.14 DHN
2.14.1 DHN Details
2.14.2 DHN Major Business
2.14.3 DHN Swine Vaccines Product and Services
2.14.4 DHN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 DHN Recent Developments/Updates
2.15 CAVAC
2.15.1 CAVAC Details
2.15.2 CAVAC Major Business
2.15.3 CAVAC Swine Vaccines Product and Services
2.15.4 CAVAC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 CAVAC Recent Developments/Updates
2.16 Virbac
2.16.1 Virbac Details
2.16.2 Virbac Major Business
2.16.3 Virbac Swine Vaccines Product and Services
2.16.4 Virbac Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Virbac Recent Developments/Updates
2.17 HVRI
2.17.1 HVRI Details
2.17.2 HVRI Major Business
2.17.3 HVRI Swine Vaccines Product and Services
2.17.4 HVRI Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 HVRI Recent Developments/Updates
2.18 Bioveta
2.18.1 Bioveta Details
2.18.2 Bioveta Major Business
2.18.3 Bioveta Swine Vaccines Product and Services
2.18.4 Bioveta Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Bioveta Recent Developments/Updates
2.19 Cavet Bio
2.19.1 Cavet Bio Details
2.19.2 Cavet Bio Major Business
2.19.3 Cavet Bio Swine Vaccines Product and Services
2.19.4 Cavet Bio Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cavet Bio Recent Developments/Updates
2.20 BIGVET Biotech
2.20.1 BIGVET Biotech Details
2.20.2 BIGVET Biotech Major Business
2.20.3 BIGVET Biotech Swine Vaccines Product and Services
2.20.4 BIGVET Biotech Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 BIGVET Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SWINE VACCINES BY MANUFACTURER
3.1 Global Swine Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Swine Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Swine Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Swine Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Swine Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Swine Vaccines Manufacturer Market Share in 2025
3.5 Swine Vaccines Market: Overall Company Footprint Analysis
3.5.1 Swine Vaccines Market: Region Footprint
3.5.2 Swine Vaccines Market: Company Product Type Footprint
3.5.3 Swine Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Swine Vaccines Market Size by Region
4.1.1 Global Swine Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Swine Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Swine Vaccines Average Price by Region (2021-2032)
4.2 North America Swine Vaccines Consumption Value (2021-2032)
4.3 Europe Swine Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Swine Vaccines Consumption Value (2021-2032)
4.5 South America Swine Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Swine Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Swine Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Swine Vaccines Consumption Value by Type (2021-2032)
5.3 Global Swine Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Swine Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Swine Vaccines Consumption Value by Application (2021-2032)
6.3 Global Swine Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Swine Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Swine Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Swine Vaccines Market Size by Country
7.3.1 North America Swine Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Swine Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Swine Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Swine Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Swine Vaccines Market Size by Country
8.3.1 Europe Swine Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Swine Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Swine Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Swine Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Swine Vaccines Market Size by Region
9.3.1 Asia-Pacific Swine Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Swine Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Swine Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Swine Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Swine Vaccines Market Size by Country
10.3.1 South America Swine Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Swine Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Swine Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Swine Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Swine Vaccines Market Size by Country
11.3.1 Middle East & Africa Swine Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Swine Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Swine Vaccines Market Drivers
12.2 Swine Vaccines Market Restraints
12.3 Swine Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Swine Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Vaccines
13.3 Swine Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Vaccines Typical Distributors
14.3 Swine Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Swine Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Swine Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Swine Vaccines Product and Services
Table 6. Merck Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Merck Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Swine Vaccines Product and Services
Table 11. Boehringer Ingelheim Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 14. Jinyu Bio-Technology Major Business
Table 15. Jinyu Bio-Technology Swine Vaccines Product and Services
Table 16. Jinyu Bio-Technology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Jinyu Bio-Technology Recent Developments/Updates
Table 18. CAHIC Basic Information, Manufacturing Base and Competitors
Table 19. CAHIC Major Business
Table 20. CAHIC Swine Vaccines Product and Services
Table 21. CAHIC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. CAHIC Recent Developments/Updates
Table 23. Tecon Basic Information, Manufacturing Base and Competitors
Table 24. Tecon Major Business
Table 25. Tecon Swine Vaccines Product and Services
Table 26. Tecon Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Tecon Recent Developments/Updates
Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
Table 29. Zoetis Major Business
Table 30. Zoetis Swine Vaccines Product and Services
Table 31. Zoetis Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Zoetis Recent Developments/Updates
Table 33. Ceva Basic Information, Manufacturing Base and Competitors
Table 34. Ceva Major Business
Table 35. Ceva Swine Vaccines Product and Services
Table 36. Ceva Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Ceva Recent Developments/Updates
Table 38. Hile Bio Basic Information, Manufacturing Base and Competitors
Table 39. Hile Bio Major Business
Table 40. Hile Bio Swine Vaccines Product and Services
Table 41. Hile Bio Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Hile Bio Recent Developments/Updates
Table 43. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 44. Chopper Biology Major Business
Table 45. Chopper Biology Swine Vaccines Product and Services
Table 46. Chopper Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Chopper Biology Recent Developments/Updates
Table 48. WINSUN Basic Information, Manufacturing Base and Competitors
Table 49. WINSUN Major Business
Table 50. WINSUN Swine Vaccines Product and Services
Table 51. WINSUN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. WINSUN Recent Developments/Updates
Table 53. Hipra Basic Information, Manufacturing Base and Competitors
Table 54. Hipra Major Business
Table 55. Hipra Swine Vaccines Product and Services
Table 56. Hipra Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Hipra Recent Developments/Updates
Table 58. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 59. Ringpu Biology Major Business
Table 60. Ringpu Biology Swine Vaccines Product and Services
Table 61. Ringpu Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Ringpu Biology Recent Developments/Updates
Table 63. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 64. ChengDu Tecbond Major Business
Table 65. ChengDu Tecbond Swine Vaccines Product and Services
Table 66. ChengDu Tecbond Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. ChengDu Tecbond Recent Developments/Updates
Table 68. DHN Basic Information, Manufacturing Base and Competitors
Table 69. DHN Major Business
Table 70. DHN Swine Vaccines Product and Services
Table 71. DHN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. DHN Recent Developments/Updates
Table 73. CAVAC Basic Information, Manufacturing Base and Competitors
Table 74. CAVAC Major Business
Table 75. CAVAC Swine Vaccines Product and Services
Table 76. CAVAC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. CAVAC Recent Developments/Updates
Table 78. Virbac Basic Information, Manufacturing Base and Competitors
Table 79. Virbac Major Business
Table 80. Virbac Swine Vaccines Product and Services
Table 81. Virbac Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Virbac Recent Developments/Updates
Table 83. HVRI Basic Information, Manufacturing Base and Competitors
Table 84. HVRI Major Business
Table 85. HVRI Swine Vaccines Product and Services
Table 86. HVRI Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. HVRI Recent Developments/Updates
Table 88. Bioveta Basic Information, Manufacturing Base and Competitors
Table 89. Bioveta Major Business
Table 90. Bioveta Swine Vaccines Product and Services
Table 91. Bioveta Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Bioveta Recent Developments/Updates
Table 93. Cavet Bio Basic Information, Manufacturing Base and Competitors
Table 94. Cavet Bio Major Business
Table 95. Cavet Bio Swine Vaccines Product and Services
Table 96. Cavet Bio Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Cavet Bio Recent Developments/Updates
Table 98. BIGVET Biotech Basic Information, Manufacturing Base and Competitors
Table 99. BIGVET Biotech Major Business
Table 100. BIGVET Biotech Swine Vaccines Product and Services
Table 101. BIGVET Biotech Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. BIGVET Biotech Recent Developments/Updates
Table 103. Global Swine Vaccines Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 104. Global Swine Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 105. Global Swine Vaccines Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 106. Market Position of Manufacturers in Swine Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 107. Head Office and Swine Vaccines Production Site of Key Manufacturer
Table 108. Swine Vaccines Market: Company Product Type Footprint
Table 109. Swine Vaccines Market: Company Product Application Footprint
Table 110. Swine Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Swine Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Swine Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 113. Global Swine Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 114. Global Swine Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 115. Global Swine Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 116. Global Swine Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 117. Global Swine Vaccines Average Price by Region (2021-2026) & (USD/K Doses)
Table 118. Global Swine Vaccines Average Price by Region (2027-2032) & (USD/K Doses)
Table 119. Global Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 120. Global Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 121. Global Swine Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Global Swine Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Global Swine Vaccines Average Price by Type (2021-2026) & (USD/K Doses)
Table 124. Global Swine Vaccines Average Price by Type (2027-2032) & (USD/K Doses)
Table 125. Global Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 126. Global Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 127. Global Swine Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 128. Global Swine Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 129. Global Swine Vaccines Average Price by Application (2021-2026) & (USD/K Doses)
Table 130. Global Swine Vaccines Average Price by Application (2027-2032) & (USD/K Doses)
Table 131. North America Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 132. North America Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 133. North America Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 134. North America Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 135. North America Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 136. North America Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 137. North America Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 138. North America Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Europe Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 140. Europe Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 141. Europe Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 142. Europe Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 143. Europe Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 144. Europe Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 145. Europe Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 146. Europe Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 147. Asia-Pacific Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 148. Asia-Pacific Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 149. Asia-Pacific Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 150. Asia-Pacific Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 151. Asia-Pacific Swine Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 152. Asia-Pacific Swine Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 153. Asia-Pacific Swine Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 154. Asia-Pacific Swine Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 155. South America Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 156. South America Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 157. South America Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 158. South America Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 159. South America Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 160. South America Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 161. South America Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 162. South America Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 163. Middle East & Africa Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 164. Middle East & Africa Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 165. Middle East & Africa Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 166. Middle East & Africa Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 167. Middle East & Africa Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 168. Middle East & Africa Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 169. Middle East & Africa Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 170. Middle East & Africa Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Swine Vaccines Raw Material
Table 172. Key Manufacturers of Swine Vaccines Raw Materials
Table 173. Swine Vaccines Typical Distributors
Table 174. Swine Vaccines Typical Customers
Table 1. Global Swine Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Swine Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Swine Vaccines Product and Services
Table 6. Merck Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Merck Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Swine Vaccines Product and Services
Table 11. Boehringer Ingelheim Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 14. Jinyu Bio-Technology Major Business
Table 15. Jinyu Bio-Technology Swine Vaccines Product and Services
Table 16. Jinyu Bio-Technology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Jinyu Bio-Technology Recent Developments/Updates
Table 18. CAHIC Basic Information, Manufacturing Base and Competitors
Table 19. CAHIC Major Business
Table 20. CAHIC Swine Vaccines Product and Services
Table 21. CAHIC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. CAHIC Recent Developments/Updates
Table 23. Tecon Basic Information, Manufacturing Base and Competitors
Table 24. Tecon Major Business
Table 25. Tecon Swine Vaccines Product and Services
Table 26. Tecon Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Tecon Recent Developments/Updates
Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
Table 29. Zoetis Major Business
Table 30. Zoetis Swine Vaccines Product and Services
Table 31. Zoetis Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Zoetis Recent Developments/Updates
Table 33. Ceva Basic Information, Manufacturing Base and Competitors
Table 34. Ceva Major Business
Table 35. Ceva Swine Vaccines Product and Services
Table 36. Ceva Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Ceva Recent Developments/Updates
Table 38. Hile Bio Basic Information, Manufacturing Base and Competitors
Table 39. Hile Bio Major Business
Table 40. Hile Bio Swine Vaccines Product and Services
Table 41. Hile Bio Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Hile Bio Recent Developments/Updates
Table 43. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 44. Chopper Biology Major Business
Table 45. Chopper Biology Swine Vaccines Product and Services
Table 46. Chopper Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Chopper Biology Recent Developments/Updates
Table 48. WINSUN Basic Information, Manufacturing Base and Competitors
Table 49. WINSUN Major Business
Table 50. WINSUN Swine Vaccines Product and Services
Table 51. WINSUN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. WINSUN Recent Developments/Updates
Table 53. Hipra Basic Information, Manufacturing Base and Competitors
Table 54. Hipra Major Business
Table 55. Hipra Swine Vaccines Product and Services
Table 56. Hipra Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Hipra Recent Developments/Updates
Table 58. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 59. Ringpu Biology Major Business
Table 60. Ringpu Biology Swine Vaccines Product and Services
Table 61. Ringpu Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Ringpu Biology Recent Developments/Updates
Table 63. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 64. ChengDu Tecbond Major Business
Table 65. ChengDu Tecbond Swine Vaccines Product and Services
Table 66. ChengDu Tecbond Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. ChengDu Tecbond Recent Developments/Updates
Table 68. DHN Basic Information, Manufacturing Base and Competitors
Table 69. DHN Major Business
Table 70. DHN Swine Vaccines Product and Services
Table 71. DHN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. DHN Recent Developments/Updates
Table 73. CAVAC Basic Information, Manufacturing Base and Competitors
Table 74. CAVAC Major Business
Table 75. CAVAC Swine Vaccines Product and Services
Table 76. CAVAC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. CAVAC Recent Developments/Updates
Table 78. Virbac Basic Information, Manufacturing Base and Competitors
Table 79. Virbac Major Business
Table 80. Virbac Swine Vaccines Product and Services
Table 81. Virbac Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Virbac Recent Developments/Updates
Table 83. HVRI Basic Information, Manufacturing Base and Competitors
Table 84. HVRI Major Business
Table 85. HVRI Swine Vaccines Product and Services
Table 86. HVRI Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. HVRI Recent Developments/Updates
Table 88. Bioveta Basic Information, Manufacturing Base and Competitors
Table 89. Bioveta Major Business
Table 90. Bioveta Swine Vaccines Product and Services
Table 91. Bioveta Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Bioveta Recent Developments/Updates
Table 93. Cavet Bio Basic Information, Manufacturing Base and Competitors
Table 94. Cavet Bio Major Business
Table 95. Cavet Bio Swine Vaccines Product and Services
Table 96. Cavet Bio Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Cavet Bio Recent Developments/Updates
Table 98. BIGVET Biotech Basic Information, Manufacturing Base and Competitors
Table 99. BIGVET Biotech Major Business
Table 100. BIGVET Biotech Swine Vaccines Product and Services
Table 101. BIGVET Biotech Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. BIGVET Biotech Recent Developments/Updates
Table 103. Global Swine Vaccines Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 104. Global Swine Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 105. Global Swine Vaccines Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 106. Market Position of Manufacturers in Swine Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 107. Head Office and Swine Vaccines Production Site of Key Manufacturer
Table 108. Swine Vaccines Market: Company Product Type Footprint
Table 109. Swine Vaccines Market: Company Product Application Footprint
Table 110. Swine Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Swine Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Swine Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 113. Global Swine Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 114. Global Swine Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 115. Global Swine Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 116. Global Swine Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 117. Global Swine Vaccines Average Price by Region (2021-2026) & (USD/K Doses)
Table 118. Global Swine Vaccines Average Price by Region (2027-2032) & (USD/K Doses)
Table 119. Global Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 120. Global Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 121. Global Swine Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Global Swine Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Global Swine Vaccines Average Price by Type (2021-2026) & (USD/K Doses)
Table 124. Global Swine Vaccines Average Price by Type (2027-2032) & (USD/K Doses)
Table 125. Global Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 126. Global Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 127. Global Swine Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 128. Global Swine Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 129. Global Swine Vaccines Average Price by Application (2021-2026) & (USD/K Doses)
Table 130. Global Swine Vaccines Average Price by Application (2027-2032) & (USD/K Doses)
Table 131. North America Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 132. North America Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 133. North America Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 134. North America Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 135. North America Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 136. North America Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 137. North America Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 138. North America Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Europe Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 140. Europe Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 141. Europe Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 142. Europe Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 143. Europe Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 144. Europe Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 145. Europe Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 146. Europe Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 147. Asia-Pacific Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 148. Asia-Pacific Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 149. Asia-Pacific Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 150. Asia-Pacific Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 151. Asia-Pacific Swine Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 152. Asia-Pacific Swine Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 153. Asia-Pacific Swine Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 154. Asia-Pacific Swine Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 155. South America Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 156. South America Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 157. South America Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 158. South America Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 159. South America Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 160. South America Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 161. South America Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 162. South America Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 163. Middle East & Africa Swine Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 164. Middle East & Africa Swine Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 165. Middle East & Africa Swine Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 166. Middle East & Africa Swine Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 167. Middle East & Africa Swine Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 168. Middle East & Africa Swine Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 169. Middle East & Africa Swine Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 170. Middle East & Africa Swine Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Swine Vaccines Raw Material
Table 172. Key Manufacturers of Swine Vaccines Raw Materials
Table 173. Swine Vaccines Typical Distributors
Table 174. Swine Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Swine Vaccines Picture
Figure 2. Global Swine Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Swine Vaccines Revenue Market Share by Type in 2025
Figure 4. CSF Vaccines Examples
Figure 5. FMD Vaccines Examples
Figure 6. Porcine Circovirus Vaccines Examples
Figure 7. PRRS Vaccines Examples
Figure 8. Others Examples
Figure 9. Global Swine Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Swine Vaccines Revenue Market Share by Application in 2025
Figure 11. Government Tender Examples
Figure 12. Market Sales Examples
Figure 13. Global Swine Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Swine Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Swine Vaccines Sales Quantity (2021-2032) & (M Doses)
Figure 16. Global Swine Vaccines Price (2021-2032) & (USD/K Doses)
Figure 17. Global Swine Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global Swine Vaccines Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of Swine Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 Swine Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 Swine Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 22. Global Swine Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global Swine Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 24. North America Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 29. Global Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global Swine Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 31. Global Swine Vaccines Average Price by Type (2021-2032) & (USD/K Doses)
Figure 32. Global Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global Swine Vaccines Revenue Market Share by Application (2021-2032)
Figure 34. Global Swine Vaccines Average Price by Application (2021-2032) & (USD/K Doses)
Figure 35. North America Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 47. France Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific Swine Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 55. China Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. India Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 75. Swine Vaccines Market Drivers
Figure 76. Swine Vaccines Market Restraints
Figure 77. Swine Vaccines Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Swine Vaccines in 2025
Figure 80. Manufacturing Process Analysis of Swine Vaccines
Figure 81. Swine Vaccines Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Swine Vaccines Picture
Figure 2. Global Swine Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Swine Vaccines Revenue Market Share by Type in 2025
Figure 4. CSF Vaccines Examples
Figure 5. FMD Vaccines Examples
Figure 6. Porcine Circovirus Vaccines Examples
Figure 7. PRRS Vaccines Examples
Figure 8. Others Examples
Figure 9. Global Swine Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Swine Vaccines Revenue Market Share by Application in 2025
Figure 11. Government Tender Examples
Figure 12. Market Sales Examples
Figure 13. Global Swine Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Swine Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Swine Vaccines Sales Quantity (2021-2032) & (M Doses)
Figure 16. Global Swine Vaccines Price (2021-2032) & (USD/K Doses)
Figure 17. Global Swine Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global Swine Vaccines Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of Swine Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 Swine Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 Swine Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 22. Global Swine Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global Swine Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 24. North America Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 29. Global Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global Swine Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 31. Global Swine Vaccines Average Price by Type (2021-2032) & (USD/K Doses)
Figure 32. Global Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global Swine Vaccines Revenue Market Share by Application (2021-2032)
Figure 34. Global Swine Vaccines Average Price by Application (2021-2032) & (USD/K Doses)
Figure 35. North America Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 47. France Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific Swine Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 55. China Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. India Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa Swine Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa Swine Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 75. Swine Vaccines Market Drivers
Figure 76. Swine Vaccines Market Restraints
Figure 77. Swine Vaccines Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Swine Vaccines in 2025
Figure 80. Manufacturing Process Analysis of Swine Vaccines
Figure 81. Swine Vaccines Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
